Written by BRYAN ANDERSON
North Carolina health officials said Monday that medically vulnerable residents with certain health conditions can get an additional dose of COVID-19 vaccine, though some have already had a third Pfizer or Moderna shot after the U.S. Food and Drug Administration approved it last week.
The FDA signed off on the additional dose after emerging data suggested people with moderately to severely compromised immune systems do not necessarily build the same level of immunity as others who are not immunocompromised.
Maura Wozniak, a 43-year-old Charlotte-area resident with cystic fibrosis, said she didn’t develop any antibodies after receiving the first two Pfizer doses. After speaking with her pharmacist shortly after the FDA approved the additional shot, she got a third Pfizer dose Saturday in Huntersville.
She hopes the third shot will give her more protection, especially against the more contagious delta variant. If nothing else, she said she’ll feel less anxious about the pandemic.
“I’m hopeful that I do get some antibodies from it,” Wozniak said. “Psychologically, it’s going to help a lot.”
The stay-at-home mother is excited to have her two 12-year-old kids return to school this month masked and in-person. But because she remains medically vulnerable and feels unsafe, she and her family will continue wearing masks indoors. Wozniak said she also has decided not to pursue as many school volunteer opportunities as she had hoped.
When she got the vaccine in March after months of waiting because the state had prioritized healthy people in older age groups over younger people like her with chronic conditions, she never imagined transmission of the virus would be as severe as it is today.
“Did I ever think in a million years we’d still be in this spot with school starting up? No, not at all,” she said.
Data from the state Department of Health and Human Services shows COVID-19 cases, hospitalizations and the share of tests coming back positive at their worst levels in more than six months.
Charlotte-Mecklenburg Schools, which is where Wozniak’s kids will return this month, is one of several public school systems heeding the advice of health experts to require students to wear masks inside classrooms. Starting Wednesday, the city of Charlotte and unincorporated parts of Mecklenburg County will impose an indoor mask mandate.
“We need more people in our community to get vaccinated, which is the best way for us to get back to normal for the long-term,” Charlotte Mayor Vi Lyles said in a statement Monday. “Unless we do better on getting shots in arms, this won’t be the last time we have to mandate masks or other measures.”
Lack of demand for vaccines has contributed to tens of thousands of doses being thrown out.
Since the beginning of vaccine distribution in December 2020, North Carolina has received more than 7.6 million doses among state providers, which excludes federal pharmacy program partners like Walgreens and CVS. Data the state health department shared with The Associated Press on Monday show more than 250,000 of the 7.6 million doses, or 3%, were unusable for any number of reasons, including nearly 52,000 expired shots, as of Aug. 2.
Despite the worsening metrics and wasted doses, North Carolinians have recently gotten vaccinated in greater numbers amid delta variant fears, employer vaccine mandates and stronger financial incentives for receiving a first dose.
More than 3 in 5 residents eligible for a COVID-19 vaccine because they are at least 12 years old have gotten at least one shot. Immunocompromised North Carolinians who are 12 and older can get a third Pfizer vaccine, while adults 18 and older qualify for an extra Moderna shot.
Photo via AP Photo/Chris Carlson.
Related Stories
‹
![]()
What Does Full Approval of Pfizer’s COVID-19 Vaccine Mean?Written by MATTHEW PERRONE What does full approval of Pfizer’s COVID-19 vaccine mean? It means Pfizer’s shot for people 16 and older has now undergone the same rigorous testing and regulatory review as dozens of other long-established vaccines. COVID-19 vaccines in the U.S. were initially rolled out under the Food and Drug Administration’s emergency use […]

US Regulators Give Full Approval to Pfizer COVID-19 VaccineWritten by LAURAN NEERGAARD and MATTHEW PERRONE The U.S. gave full approval to Pfizer’s COVID-19 vaccine on Monday, a milestone that may help lift public confidence in the shots as the nation battles the most contagious coronavirus mutant yet. The vaccine made by Pfizer and its partner BioNTech now carries the strongest endorsement from the […]

US Clears Updated COVID Boosters Targeting Newest VariantsWritten by LAURAN NEERGAARD The U.S. on Wednesday authorized its first update to COVID-19 vaccines, booster doses that target today’s most common omicron strain. Shots could begin within days. The move by the Food and Drug Administration tweaks the recipe of shots made by Pfizer and rival Moderna that already have saved millions of lives. The hope […]
![]()
Marathon US Hearings To Decide Fate of COVID Shots for TotsWritten by LAURAN NEERGAARD Parents anxious to finally vaccinate their youngest children against COVID-19, strap in: A lot is set to happen over the next week. On Wednesday, both Moderna and Pfizer will have to convince what’s essentially a science court — advisers to the Food and Drug Administration — that their shots work well in babies, toddlers and […]

Moderna Says Its Low-Dose COVID Shots Work for Kids Under 6Written by LAURAN NEERGAARD Moderna’s COVID-19 vaccine works in babies, toddlers and preschoolers, the company announced Wednesday — and if regulators agree it could mean a chance to finally start vaccinating the littlest kids by summer. Moderna said in the coming weeks it would ask regulators in the U.S. and Europe to authorize two small-dose […]

Pfizer Says COVID-19 Vaccine More Than 90% Effective in KidsWritten by LAURAN NEERGAARD and MATTHEW PERRONE Kid-size doses of Pfizer’s COVID-19 vaccine appear safe and nearly 91% effective at preventing symptomatic infections in 5- to 11-year-olds, according to study details released Friday as the U.S. considers opening vaccinations to that age group. The shots could begin in early November — with the first children […]

FDA Panel Endorses Lower-Dose Moderna COVID Shot for BoosterWritten by LAURAN NEERGAARD and MATTHEW PERRONE U.S. health advisers said Thursday that some Americans who received Moderna’s COVID-19 vaccine should get a half-dose booster to bolster protection against the virus. The panel of advisers to the Food and Drug Administration voted unanimously to recommend a booster shot for seniors, adults with other health problems, […]

Next on FDA’s Agenda: Booster Shots of Moderna, J&J VaccinesWritten by LAURAN NEERGAARD and MATTHEW PERRONE With many Americans who got Pfizer vaccinations already rolling up their sleeves for a booster shot, millions of others who received the Moderna or Johnson & Johnson vaccine wait anxiously to learn when it’s their turn. Federal regulators begin tackling that question this week. On Thursday and Friday, […]

Pfizer Says COVID-19 Vaccine Works in Kids Ages 5 to 11Written by LAURAN NEERGAARD Pfizer said Monday its COVID-19 vaccine works for children ages 5 to 11 and that it will seek U.S. authorization for this age group soon — a key step toward beginning vaccinations for youngsters. The vaccine made by Pfizer and its German partner BioNTech already is available for anyone 12 and […]

Medically At-Risk North Carolinians Can Get Third COVID ShotWritten by BRYAN ANDERSON North Carolina health officials said Monday that medically vulnerable residents with certain health conditions can get an additional dose of COVID-19 vaccine, though some have already had a third Pfizer or Moderna shot after the U.S. Food and Drug Administration approved it last week. The FDA signed off on the additional dose after […]
›